CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ -- • An early-phase ...

Marine biotechnology and material science convergence is fundamentally transforming packaging capabilities. The integration of bioactive compound extraction, nanoencapsulation, controlled release ...

The Central Board of Secondary Education (CBSE) will release the CBSE Admit Card 2026 for Class 10 and 12 board exams soon.

The company also announced the appointment of Han Lee, Ph.D., as co-chief executive officer (CEO), and the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...

The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

CBSE Class 12 Biology Pre Board Sample Paper 2025-2026: The CBSE Class 12 Biology Pre-Board Exam 2026 will be conducted on 27 March 2026 (Friday). As the exam date approaches, students are preparing ...

Winge: Senior year is filled with excitement, anticipation and likely some stress. Students can follow these guidelines to finish strong when up against a deadline. Winge: It may sound like an ...

If you are a Class 12 science student, chances are you have come across this question more than once. Should you choose Pharmacy or Biotechnology? Both sound promising. Both fall under life sciences.

According to details made available, the incident occurred on Thursday night at Itakeate Isao, where the student was reportedly bitten by a snake under circumstances that are still being discussed ...

BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the "Company”), a biotech company focused on advancing cancer treatments, today announced that it ...